ArticleScientific reports2026
Plant extract mixture shows anti-inflammatory and barrier-strengthening effects and activates aryl hydrocarbon receptor in a 2D psoriasis model.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammation, defect skin barrier and oxidative stress contribute to the pathogenesis of psoriasis, a common chronic inflammatory skin disease. The aryl hydrocarbon receptor (AhR) represents a promising treatment target as its activation by specific ligands attenuates inflammatory processes and barrier disruption in the epidermis. Recently, we demonstrated that a plant extract mixture consisting of apple, curly kale and green tea activates the AhR and shows beneficial effects in an atopic dermatitis skin model. The aim of this study is to investigate potential beneficial effects of the plant extract also in psoriasis using an in vitro 2D psoriasis model. Gene expression analysis revealed that the extract restored the expression of the skin barrier molecule filaggrin, reduced the expression of inflammatory markers and inhibited the psoriasis-typical overexpression of antimicrobial peptides. A luciferase reporter assay demonstrated that the extract activated AhR in the 2D psoriasis model. Suppression of AhR via siRNA revealed that the filaggrin induction was mediated by AhR activation, while the anti-inflammatory effects were AhR-independent. Furthermore, the extract exhibited antioxidant activity against intracellular reactive oxygen species. In summary, the anti-inflammatory, antioxidant and barrier-strengthening effects of the plant extract mixture in the 2D psoriasis model suggest that the plant extract may represent a promising topical treatment option in psoriasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.